Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Digital Mammography Trend Improves Cancer Detection Rates

By HospiMedica International staff writers
Posted on 09 Mar 2017
A new study that set out to establish performance benchmarks for digital mammography screening suggests that the shift from film has improved cancer detection rates.

Researchers at the University of Vermont, Massachusetts General Hospital, and other institutions conducted a study to measure the performance of digital screening mammography, based on data collected from six Breast Cancer Surveillance Consortium (BCSC) registries that included 401,548 examinations of 265,360 women conducted between 2007 and 2013. More...
Mammography indication and assessments by 418 radiologists in 92 radiology facilities were linked with cancer diagnoses from state cancer registries.

The researchers found that compared with the results from an earlier BCSC benchmarks publication, the cancer detection rate rose from 25.3 per 1,000 in 2005 to 34.7 per 1,000 in the new study. According to the researchers, the change may reflect improvements in mammography imaging technology, which permit the visualization of smaller lesions and greater detection of calcifications, resulting in increased cancer detection. But alongside the improved cancer detection rate, the abnormal interpretation rate rose from 8% in 2005 to 12.6%.

Another concerning trend was the drop in positive predictive value (PPV), from 31.5% in 2005 to 27.5% in the new study. The lower PPV results are a direct result of the abnormal interpretation rate increasing much more than the cancer detection rate, according to the researchers, suggesting that improvements in imaging may do more to permit the visualization of additional findings, but do not aid radiologists in discriminating between benign and malignant findings. The study was published on December 5, 2016, in Radiology.

“An increase in mammographic cancer detection does not necessarily have to come with a substantial rise in the abnormal interpretation rate. For instance, Europe has been able to achieve cancer detection rates similar to U.S. rates, with much lower abnormal interpretation rates,” said lead author Brian Sprague, PhD, of the UVM Cancer Center. “Increased utilization of double reading in Europe, where at least two radiologists interpret the same exam, may be a factor. In addition, variables like fear of litigation can affect abnormal interpretation rates.”

Digital mammography screening now includes digital breast tomosynthesis (DBT), which can increase breast cancer detection rates even further. DBT mammograms use low dose x-rays to create a three dimensional (3D) image of the breast, which can then be viewed in narrow slices, similar to CT scans. While in conventional 2D mammography overlapping tissues can mask suspicious areas, 3D images eliminate the overlap, making abnormalities easier to recognize. It is estimated that 3D DBT will replace conventional mammography within ten years.


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Fetal Monitor
BT-380
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.